Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy

Megan Smith-Uffen, John Park, Andrew Parsonson, Anuradha Vasista

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	431
Pages (from-to)	A452
Number of pages	1
Journal	Journal for ImmunoTherapy of Cancer
Volume	10
Issue number	Supplement 2
DOIs	https://doi.org/10.1136/JITC-2022-SITC2022.0431
Publication status	Published - Nov 2022
Externally published	Yes
Event	Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting - Boston, United States Duration: 8 Nov 2022 → 12 Nov 2022

Access to Document

@article{ac0dbdcb5ca3474a81aaa83baf545cf2,

title = "Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy",

author = "Megan Smith-Uffen and John Park and Andrew Parsonson and Anuradha Vasista",

year = "2022",

month = nov,

doi = "10.1136/JITC-2022-SITC2022.0431",

language = "English",

volume = "10",

pages = "A452",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "Springer, Springer Nature",

number = "Supplement 2",

note = "Society for Immunotherapy of Cancer{\textquoteright}s (SITC) 37th Annual Meeting ; Conference date: 08-11-2022 Through 12-11-2022",

}

TY - JOUR

T1 - Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy

AU - Smith-Uffen, Megan

AU - Park, John

AU - Parsonson, Andrew

AU - Vasista, Anuradha

PY - 2022/11

Y1 - 2022/11

U2 - 10.1136/JITC-2022-SITC2022.0431

DO - 10.1136/JITC-2022-SITC2022.0431

M3 - Meeting abstract

SN - 2051-1426

VL - 10

SP - A452

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

IS - Supplement 2

M1 - 431

T2 - Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

Y2 - 8 November 2022 through 12 November 2022

ER -